208 related articles for article (PubMed ID: 22673527)
1. Neonatal neuroblastoma.
Fisher JPH; Tweddle DA
Semin Fetal Neonatal Med; 2012 Aug; 17(4):207-215. PubMed ID: 22673527
[TBL] [Abstract][Full Text] [Related]
2. Retinoblastoma and Neuroblastoma Predisposition and Surveillance.
Kamihara J; Bourdeaut F; Foulkes WD; Molenaar JJ; Mossé YP; Nakagawara A; Parareda A; Scollon SR; Schneider KW; Skalet AH; States LJ; Walsh MF; Diller LR; Brodeur GM
Clin Cancer Res; 2017 Jul; 23(13):e98-e106. PubMed ID: 28674118
[TBL] [Abstract][Full Text] [Related]
3. Biological and Genetic Features of Neuroblastoma and Their Clinical Importance.
Aygun N
Curr Pediatr Rev; 2018; 14(2):73-90. PubMed ID: 29380702
[TBL] [Abstract][Full Text] [Related]
4. Genetic susceptibility to neuroblastoma.
Tolbert VP; Coggins GE; Maris JM
Curr Opin Genet Dev; 2017 Feb; 42():81-90. PubMed ID: 28458126
[TBL] [Abstract][Full Text] [Related]
5. Clinical feature of anaplastic lymphoma kinase-mutated neuroblastoma.
Ogura T; Hiyama E; Kamei N; Kamimatsuse A; Ueda Y; Ogura K
J Pediatr Surg; 2012 Oct; 47(10):1789-96. PubMed ID: 23084186
[TBL] [Abstract][Full Text] [Related]
6. ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome.
Bourdeaut F; Ferrand S; Brugières L; Hilbert M; Ribeiro A; Lacroix L; Bénard J; Combaret V; Michon J; Valteau-Couanet D; Isidor B; Rialland X; Poirée M; Defachelles AS; Peuchmaur M; Schleiermacher G; Pierron G; Gauthier-Villars M; Janoueix-Lerosey I; Delattre O;
Eur J Hum Genet; 2012 Mar; 20(3):291-7. PubMed ID: 22071890
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells.
Schönherr C; Ruuth K; Kamaraj S; Wang CL; Yang HL; Combaret V; Djos A; Martinsson T; Christensen JG; Palmer RH; Hallberg B
Oncogene; 2012 Dec; 31(50):5193-200. PubMed ID: 22286764
[TBL] [Abstract][Full Text] [Related]
8. Targeted expression of mutated ALK induces neuroblastoma in transgenic mice.
Heukamp LC; Thor T; Schramm A; De Preter K; Kumps C; De Wilde B; Odersky A; Peifer M; Lindner S; Spruessel A; Pattyn F; Mestdagh P; Menten B; Kuhfittig-Kulle S; Künkele A; König K; Meder L; Chatterjee S; Ullrich RT; Schulte S; Vandesompele J; Speleman F; Büttner R; Eggert A; Schulte JH
Sci Transl Med; 2012 Jul; 4(141):141ra91. PubMed ID: 22764207
[TBL] [Abstract][Full Text] [Related]
9. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
[TBL] [Abstract][Full Text] [Related]
10. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97.
Hero B; Simon T; Spitz R; Ernestus K; Gnekow AK; Scheel-Walter HG; Schwabe D; Schilling FH; Benz-Bohm G; Berthold F
J Clin Oncol; 2008 Mar; 26(9):1504-10. PubMed ID: 18349403
[TBL] [Abstract][Full Text] [Related]
11. Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis.
Krona C; Carén H; Sjöberg RM; Sandstedt B; Laureys G; Kogner P; Martinsson T
Int J Oncol; 2008 Mar; 32(3):575-83. PubMed ID: 18292934
[TBL] [Abstract][Full Text] [Related]
12. PHOX2B is a reliable immunomarker in distinguishing peripheral neuroblastic tumours from CNS embryonal tumours.
Alexandrescu S; Paulson V; Dubuc A; Ligon A; Lidov HG
Histopathology; 2018 Sep; 73(3):483-491. PubMed ID: 29758594
[TBL] [Abstract][Full Text] [Related]
13. Oncologic Phenotype of Peripheral Neuroblastic Tumors Associated With PHOX2B Non-Polyalanine Repeat Expansion Mutations.
Heide S; Masliah-Planchon J; Isidor B; Guimier A; Bodet D; Coze C; Deville A; Thebault E; Pasquier CJ; Cassagnau E; Pierron G; Clément N; Schleiermacher G; Amiel J; Delattre O; Peuchmaur M; Bourdeaut F
Pediatr Blood Cancer; 2016 Jan; 63(1):71-7. PubMed ID: 26375764
[TBL] [Abstract][Full Text] [Related]
14. [Opsoclonus-myoclonus syndrome in children with neuroblastoma: description of 3 cases].
Garus K; Balwierz W; Skowronek B; Szweda E; Kroczka S; Moryl-Bujakowska A
Przegl Lek; 2010; 67(6):427-9. PubMed ID: 21344775
[TBL] [Abstract][Full Text] [Related]
15. The Phox2B homeobox gene is mutated in sporadic neuroblastomas.
van Limpt V; Schramm A; van Lakeman A; Sluis P; Chan A; van Noesel M; Baas F; Caron H; Eggert A; Versteeg R
Oncogene; 2004 Dec; 23(57):9280-8. PubMed ID: 15516980
[TBL] [Abstract][Full Text] [Related]
16. Management of Neuroblastoma: ICMR Consensus Document.
Bansal D; Totadri S; Chinnaswamy G; Agarwala S; Vora T; Arora B; Prasad M; Kapoor G; Radhakrishnan V; Laskar S; Kaur T; Rath GK; Bakhshi S
Indian J Pediatr; 2017 Jun; 84(6):446-455. PubMed ID: 28367616
[TBL] [Abstract][Full Text] [Related]
17. PHOX2B reliably distinguishes neuroblastoma among small round blue cell tumours.
Hung YP; Lee JP; Bellizzi AM; Hornick JL
Histopathology; 2017 Nov; 71(5):786-794. PubMed ID: 28640941
[TBL] [Abstract][Full Text] [Related]
18. High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma.
Schulte JH; Bachmann HS; Brockmeyer B; Depreter K; Oberthür A; Ackermann S; Kahlert Y; Pajtler K; Theissen J; Westermann F; Vandesompele J; Speleman F; Berthold F; Eggert A; Brors B; Hero B; Schramm A; Fischer M
Clin Cancer Res; 2011 Aug; 17(15):5082-92. PubMed ID: 21632861
[TBL] [Abstract][Full Text] [Related]
19. Germline gain-of-function mutations of ALK disrupt central nervous system development.
de Pontual L; Kettaneh D; Gordon CT; Oufadem M; Boddaert N; Lees M; Balu L; Lachassinne E; Petros A; Mollet J; Wilson LC; Munnich A; Brugière L; Delattre O; Vekemans M; Etchevers H; Lyonnet S; Janoueix-Lerosey I; Amiel J
Hum Mutat; 2011 Mar; 32(3):272-6. PubMed ID: 21972109
[TBL] [Abstract][Full Text] [Related]
20. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.
Bourdeaut F; Trochet D; Janoueix-Lerosey I; Ribeiro A; Deville A; Coz C; Michiels JF; Lyonnet S; Amiel J; Delattre O
Cancer Lett; 2005 Oct; 228(1-2):51-8. PubMed ID: 15949893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
